Inhibition of contact activation by a kininogen peptide (HKH20) derived from domain 5

International Immunopharmacology

Volumn 2, Issue 13-14, 2002, Pages 1875-1885

  Nakazawa, Yoshitaka ^a   Joseph, Kusumam ^a   Kaplan, Allen P ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Contact activation; Inhibition; Kininogen

Indexed keywords

AMPHOTERICIN B; AMYLOID BETA PROTEIN; ASPARTYLCYSTEINYLASPARAGINYLALANYLGLUTAMYLVALYLTYROSYLVALYLVALYLPROLYLTRYPT OPHYLGLUTAMYLLYSYLLYSYLISOLEUCYLTYROSYLPROLYLTHREONYLVALYLASPARAGINYLCYSTEINYLGL UTAMYLPROLYLLEUCYLGLYCYLMETHIONINE; BIOTIN; BLOOD CLOTTING FACTOR 12; DEXTRAN SULFATE; HIGH MOLECULAR WEIGHT KININOGEN; HISTIDYLGLUTAMINYLGLYCYLGLYCYLHISTIDYLVALYLLEUCYLASPARTYLHISTIDYLGLYCYLHIST IDYLLYSYLHISTIDYLLYSYLHISTIDYLGLYCYLHISTIDYLGLYCYLHISTIDYLGLYCINE; HISTIDYLLYSYLHISTIDYLGLYCYLHISTIDYLGLYCYLGLYCYLGLYCYLGLYCYLGLYCYLGLYCYLGLYC YLGLYCYLGLYCYLLYSYLLYSYLASPARAGINYLGLYCYLLYSYLHISTIDINE; HISTIDYLLYSYLHISTIDYLGLYCYLHISTIDYLGLYCYLHISTIDYLGLYCYLLYSYLGLYCYLLYSYLASPA RAGINYLLYSYLGLYCYLLYSYLLYSYLASPARAGINYLGLYCYLLYSYLHISTIDINE; IMMUNOGLOBULIN HEAVY CHAIN; KININOGEN; LIGAND; LYSYLGLYCYLLYSYLLYSYLASPARAGINYLGLYCYLLYSYLHISTIDYLASPARAGINYLGLYCYLTRYPTOP HYLLYSYLTHREONYLGLUTAMYLHISTIDYLLEUCYLALANYLSERYLSERYLSERINE; MEMBRANE PROTEIN; PENICILLIN G; PLASMA PROTEIN; PREKALLIKREIN; RECOMBINANT PROTEIN; STREPTOMYCIN; UNCLASSIFIED DRUG; ZINC ION; C1QBP PROTEIN, HUMAN; CARRIER PROTEIN; COMPLEMENT 1Q RECEPTOR; COMPLEMENT RECEPTOR; HERMES ANTIGEN; MITOCHONDRIAL PROTEIN; PEPTIDE FRAGMENT;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ARTICLE; BIOTINYLATION; CARBOXY TERMINAL SEQUENCE; CELL INTERACTION; CELL SURFACE; COMPARATIVE STUDY; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN ISOLATION; PROTEIN PROTEIN INTERACTION; BINDING COMPETITION; CELL CULTURE; CYTOLOGY; METABOLISM; MOLECULAR GENETICS; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; ANTIGENS, CD44; BINDING, COMPETITIVE; BIOTINYLATION; CARRIER PROTEINS; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FACTOR XII; HUMANS; KININOGEN, HIGH-MOLECULAR-WEIGHT; MEMBRANE GLYCOPROTEINS; MITOCHONDRIAL PROTEINS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PREKALLIKREIN; RECEPTORS, COMPLEMENT; UMBILICAL VEINS;

EID: 0036891758     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(02)00182-0     Document Type: Article

References (34)

1. Kaplan A.P., Silverberg M. The coagulation-kinin pathway of human plasma. Blood. 70:1987;1-15.
2. Brunnee T., Reddigari S., Shibayama Y., Kaplan A.P., Silverberg M. Mast cell heparin activates the contact system: a link to kinin generation in allergic diseases. Clin. Exp. Allergy. 27:1997;653-669.
3. Silverberg M., Diehl S.V. The activation of the contact system of human plasma by polysaccharide sulfates. Ann. N.Y. Acad. Sci. 516:1987;268-279.
4. Shore J.D., Day D.E., Bock P.E., Olson S.J. Acceleration of surface-dependent autocatalytic activation of blood coagulation Factor XII by divalent metal ions. Biochemistry. 26:1987;2250-2258.
5. Schousboe I. The inositol-phospholipid-accelerated activation of prekallikrein by activated Factor XII at physiological ionic strength requires zinc ions and high-Mr kininogen. Eur. J. Biochem. 193:1990;495-499.
6. Herwald H., Morgelin M., Svenosoni H.G., Sjobring U. Zinc-dependent conformational changes in domain D5 of high molecular mass kininogen modulate contact activation. Eur. J. Biochem. 268:2001;396-404.
7. 2+-binding sites in Factor XII and its activation derivatives. Eur. J. Biochem. 247:1997;491-496.
8. Schmaier A.H., Kuo A., Lundberg D., Murray S., Cines D.B. The expression of high molecular weight kininogen on human umbilical vein endothelial cells. J. Biol. Chem. 263:1988;16327-16333.
9. van Iwaarden F., deGroot P.G., Bouma B.N. The binding of high molecular weight kininogen to cultured human endothelial cells. J. Biol. Chem. 263:1988;4698-4703.
10. Greengard J.S., Griffin J.H. Receptors for high molecular weight kininogen on stimulated washed platelets. Biochemistry. 23:1984;6863-6869.
11. Meloni F.J., Gustafson E.J., Schmaier A.H. High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage. Blood. 79:1992;1233-1244.
12. Joseph K., Ghebrehiwet B., Peerschke E.I.B., Reid K.B.M., Kaplan A.P. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and Factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1qR). Proc. Natl. Acad. Sci. U. S. A. 93:1996;8552-8557.
13. Herwald H., Dedio J., Kellner R., Loos M., Muller-Esterl W. Isolation and characterization of the kininogen binding protein p33 from endothelial cells. J. Biol. Chem. 271:1996;13040-13047.
14. Hasan A.A.K., Zisman T., Schmaier A.H. Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells. Proc. Natl. Acad. Sci. 95:1998;3615-3620.
15. Joseph K., Ghebrehiwet B., Kaplan A.P. Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells. Clin. Immunol. 92:1999;246-255.
16. Colman R.W., Pixley R.A., Najamunnisa S., Van W., Wang J., Mazar A.et al. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor. J. Clin. Invest. 100:1997;1481-1487.
17. Shibayama Y., Joseph K., Nakazawa Y., Ghebrehiwet B., Peerschke E.I.B., Kaplan A.P. Zinc-dependent activation of the plasma kinin-forming cascade by aggregated β amyloid protein. Clin. Immunol. 90:1999;89-99.
18. Shoji M., Golde T.E., Ghise J., Cheung T.T., Estus S., Shaffer L.M.et al. Production of Alzheimer amyloid beta protein by normal proteolytic processing. Science. 258:1992;126-129.
19. Hasan A.A., Cines D.B., Herwald H., Schmaier A.H., Muller-Esterl W. Mapping the cell binding site on high molecular weight kininogen domain 5. J. Biol. Chem. 270:1995;19256-19261.
20. Herwald H., Hasan A.A., Godovac-Zimmerman J., Schmaier A.H., Muller-Esterl W. Identification of an endothelial cell binding site on kininogen domain D3. J. Biol. Chem. 270:1995;14634-14642.
21. Reddigari S.R., Kuna P., Miragliotta G.F., Shibayama Y., Nishikawa K., Kaplan A.P. Human high molecular weight kininogen binds to human umbilical vein endothelial cells via its heavy and light chains. Blood. 81:1993;1306-1311.
22. Ghebrehiwet B., Lim B.-L., Peerschke E.I.B., Willis A.C., Reid K.B.M. Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q. J. Exp. Med. 179:1994;1809-1821.
23. Meloni F.J., Schmaier A.H. Low molecular weight kininogen binds to platelets to modulate thrombin-induced platelet activation. J. Biol. Chem. 266:1991;6786-6794.
24. Jiang Y., Muller-Esterl W., Schmaier A.H. Domain 3 of kininogens contains a cell-binding site and a site that modifies thrombin activation of platelets. J. Biol. Chem. 267:1992;3712-3717.
25. Chavakis T., Kanse S.M., Pixley R.A., May A.E., Salas-Isordia I., Colman R.W.et al. Regulation of leucocyte recruitment by polypeptides derived from high molecular weight kininogen. FASEB J. 15:2001;2365-2376.
26. Renne T., Dideo J., David G., Muller-Esterl W. High molecular weight kininogen utilizes hepatan sulfate proteoglycans for accumulation on endothelial cells. J. Biol. Chem. 275:2000;33688-33696.
27. Joseph K., Shibayama Y., Ghebrehiwet B., Kaplan A.P. Factor XII-dependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin 1. Thromb. Haemost. 85:2001;119-124.
28. Shemada T., Kato H., Iwanaga S. Accelerating effect of zinc ion on the surface mediated activation of Factor XII and kallikrein. J. Biochem. 102:1987;913-921.
29. Han Y.N., Kato H., Iwanaga S., Suzuki T. Primary structure of bovine plasma high molecular weight kininogen. The amino acid sequence of a glycopeptide portion (fragment 1) following the C-terminus of the bradykinin moiety. J. Biol. Chem. 263:1976;12948-12953.
30. Sugo T., Ikara N., Kato H., Iwanaga S., Fujii S. Functional sites of bovine high molecular weight kininogen as a cofactor in kaolin-mediated activation of Factor XII (Hageman Factor). Biochemistry. 19:1980;3215-3220.
31. Colman R.W., Schmaier A.H. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood. 90:1997;3819-3843.
32. DeLaCadena R.A., Colman R.W. The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface. Protein Sci. 1:1992;151-160.
33. Griffin J.H., Cochrane C.G. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman Factor. Proc. Natl. Acad. Sci. 73:1976;2554-2558.
34. Silverberg M., Nicoll J.E., Kaplan A.P. The mechanism by which the light chain of cleaved HMW-kinogen augments the activation of prekallikrein, Factor XI, and Hageman Factor. Thromb. Res. 20:1980;173-189.